The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients
Seminars in Dialysis · 2022-05 · 35 (3) · 222-227
DOI: 10.1111/sdi.13011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Dialysis, online erschienen am 13.08.2021. Verfasst von Fatma Betul Guzel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Kahramanmaraş Necip Fazil City Hospital, Kahramanmaraş, Turkey. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Vascular Stiffness. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Introduction
The main cause of death in hemodialysis patients is cardiovascular diseases. Increased arterial stiffness is a predictor of cardiovascular events for hemodialysis patients. Among the nondialysis patient population, arterial stiffness increases in those with hepatic fibrosis and nonalcoholic fatty liver disease. This study aims to examine the relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients for the first time in the literature. Material and method The study includes chronic hemodialysis patients over 18 years of age who had been treated for hemodialysis for at least 6 months. Patients with chronic liver disease, chronic viral hepatitis (HBV and HCV), alcohol use, or liver disease accompanied by polycystic kidney disease and active infection were excluded. Hepatic fibrosis scores were measured using the FibroScan device. Single‐cuff Mobil‐o‐Graph was used for measurement of arterial stiffness.
Results
Fifty‐nine patients were enrolled; 54.2% of the patients were male, and the mean age was 53.9 ± 12.9 years. Thirty‐nine percent of the patients had diabetes. Average pulse wave velocity (PWV) value of the patients was 8.3 ± 1.6 m/s, and it had positive correlation with age, CAP score, fibrosis score, and body mass index and showed negative correlation to albumin. It was seen that the patients with a PWV value ≥ 10 m/s have significantly higher CAP score compared with the patients with a PWV < 10 m/s. When the factors predicting PWV were examined in the regression analysis, age and systolic blood pressure were found to be determinants.
Conclusion
Increased hepatic fibrosis in hemodialysis patients is associated with increased arterial stiffness, but this relationship is not independent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Internal Medicine Department, Kahramanmaraş Necip Fazil City Hospital, Kahramanmaraş, Turkey.
- Faculty of Medicine, Nephrology Department, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey.
- Faculty of Medicine, Gastroenterology Department, Kahramanmaraş Sütçü İmam University, Kahramanmaraş, Turkey.
- Internal Medicine Department, Ankara Etimesgut Şehit Sait Ertürk State Hospital, Ankara, Turkey.
ORCID-Profile: Fatma Betul Guzel, Ilyas Ozturk, Kadir Gisi, Murat Ispiroglu, Gulsum Akkus, Ertugrul Erken, Orcun Altunoren, Ozkan Gungor
Zitieren
APA
Guzel, F. B., Ozturk, I., Gisi, K., Ispiroglu, M., Akkus, G., Erken, E., Altunoren, O., & Gungor, O. (2022). The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients. Seminars in Dialysis, 35(3), 222-227. https://doi.org/10.1111/sdi.13011
Vancouver
Guzel FB, Ozturk I, Gisi K, Ispiroglu M, Akkus G, Erken E, et al. The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients. Seminars in Dialysis. 2022;35(3):222-227. doi:10.1111/sdi.13011
BibTeX
@article{Guzel2022,
author = {Guzel, Fatma Betul and Ozturk, Ilyas and Gisi, Kadir and Ispiroglu, Murat and Akkus, Gulsum and Erken, Ertugrul and Altunoren, Orcun and Gungor, Ozkan},
title = {The relationship between hepatic fibrosis and arterial stiffness in hemodialysis patients},
journal = {Seminars in Dialysis},
year = {2022},
volume = {35},
number = {3},
pages = {222--227},
doi = {10.1111/sdi.13011}
}
EUVIMED